Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 5186-5188, Vol. 69, No. 8
Unité de Pathogénie
Bactérienne des Muqueuses, Institut Pasteur, Paris 75724, France
Received 26 February 2001/Returned for modification 18 April
2001/Accepted 14 May 2001
The effect of low-dose antigen exposure on the development of
immunity to Helicobacter pylori infection was studied in
outbred mice. Animals that were primed with a subinfectious number of H. pylori bacteria exhibited significantly lower
bacterial loads after challenge with an infectious dose of pathogen
(versus controls, P < 0.05).
The vast majority of individuals who
are colonized with Helicobacter pylori remain infected
despite the development of vigorous immune responses to the bacterium
(5). For this reason, it is generally assumed that host
immune responses are ineffective in clearing the infection.
Nevertheless, studies on H. pylori seroprevalence in humans
showed that up to 1.8% of individuals who were initially identified as
being H. pylori positive by serology subsequently became
negative upon retesting (15, 23, 24). It was suggested
that this seroreversion in H. pylori-infected individuals
was due to spontaneous elimination of the bacterium by the host
(24). In such instances, however, the eradication of
H. pylori as a consequence of antimicrobial treatment for
unrelated infections could not be excluded.
The most compelling evidence for spontaneous elimination of H. pylori infection has come from nonhuman primate studies (6, 7). It was shown that certain monkeys developed transient
infections after inoculation with H. pylori strains and
that, in the early stages of colonization, individual monkeys displayed
varying susceptibilities to different H. pylori strains
(6, 7).
The type of host T helper (Th) cell phenotype induced during infection
largely determines the outcome (protection or pathogenesis) of host
immune responses. The Th response phenotype occurring in the host can
be influenced by a multitude of factors, including the local cytokine
environment and the size of the antigen or inoculum dose (1, 3,
4, 12, 20). In the Leishmania mouse infection model, it was
shown that BALB/c mice that were exposed to a low-dose inoculum of
Leishmania major parasites became resistant to infection
despite the innate susceptibility of this mouse strain to L. major infection (3). This resistance was accompanied
by a switch of the default Th response of BALB/c animals from a T
helper 2 (Th2) type towards a dominant Th1 phenotype, thus mimicking
the responses that spontaneously occur in
Leishmania-resistant C57BL/6 mice (17, 18).
The aim of the present study was to determine whether exposure to a
low-dose inoculum of H. pylori might confer immunity to infection in susceptible mice. To ensure diversity of host immune responses, we used an outbred mouse strain which had previously been
shown to be highly susceptible to infection with the mouse-adapted H. pylori SS1 isolate (9, 16). Thus, 6-week-old
specific-pathogen-free outbred Swiss mice (Centre d'Elevage R. Janvier, Le-Genest-St-Isle, France) were divided into three groups.
Animals either were left untreated ("naive" animals; n = 5) or were administered intragastrically a single low-dose
inoculum containing 15 CFU of H. pylori SS1 prepared in
peptone trypsin broth (n = 19) or broth medium alone (n = 10). The minimum infectious dose of H. pylori SS1 for Swiss mice was previously determined to be
equivalent to 102 CFU (9). One month later,
H. pylori serum antibody levels in the mice were determined
and compared to those in animals that had received no treatment
(10). All animals were immunoglobulin G (IgG) seronegative
for H. pylori (results not shown). Based on previous work
(9), it was possible to conclude that the primed mice had
not become infected with H. pylori. In addition, the
serological data confirmed that the animals were free of intestinal Helicobacter spp. and therefore had not previously been
exposed to Helicobacter antigens.
Mice primed with a low-dose inoculum ("primed/challenged" group)
and those that had received peptone trypsin broth
("naive/challenged" group) were subsequently administered a
challenge dose containing 104 CFU of H. pylori
SS1. The animals were sacrificed 2 months postchallenge. Gastric tissue
samples taken from the animals were homogenized, and the bacterial
loads were determined by quantitative culture as previously described
(9). At this time point, primed/challenged mice had
significantly reduced gastric H. pylori loads compared to
those from the naive/challenged group (4.2 log CFU/g versus 5.5 log
CFU/g; Mann-Whitney test, P < 0.05; Fig.
1). This is a particularly striking
result given the outbred genetic background of the animals. Indeed, it
has been shown that outbred mice do not respond to low doses of antigen
in a genetically restricted manner (8, 22). In addition,
62% (11/19) of the primed/challenged mice had undetectable levels of
bacteria in their gastric mucosa following challenge versus 2 out of 10 of the naive/challenged mice (Fisher's exact test, P = 0.11). Although not statistically significant, the absence of
detectable infection in these mice is worthy of note because other
workers have been unable to achieve sterilizing immunity (as defined by
culture negativity) against H. pylori infection in mice
vaccinated with highly immunogenic H. pylori
antigen-adjuvant preparations (11, 13, 14).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.5186-5188.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Effect of Low-Dose Antigen Exposure on Development
of Immunity to Helicobacter pylori Infection in
Mice
and
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (14K):
[in a new window]
FIG. 1.
H. pylori bacterial loads determined from the
gastric biopsies of mice. Control animals ("naive," squares) were
left untreated throughout, while the other groups were given either
peptone trypsin broth ("naive/challenged," circles) or a low-dose
H. pylori inoculum ("primed/challenged," diamonds) prior
to challenge with an infectious pathogen dose. Each point corresponds
to the mean value for a mouse, determined in duplicate. Horizontal bars
represent the geometric means for each group of mice. The sensitivity
of detection of the assay is indicated by a dashed horizontal line.
The results of H. pylori-specific serum and gastric antibody
determinations were highly predictive of the culture status of the
animals (Fig. 2). All culture-positive mice had increased levels of
serum (IgG and IgA) and gastric (IgG and IgM) antibodies (Fig. 2A and
B). Conversely, only 2 of the 11 culture-negative mice from the
primed/challenged group had raised levels of H. pylori-specific serum IgG antibodies, while one of these mice also
had increased levels of specific IgG, IgM, and IgA antibodies in its
gastric contents (Fig. 2A and
B). It is possible that
the infection had been suppressed below the level of detection in these
two antibody-positive animals. Nevertheless, the data strongly confirmed the absence of H. pylori infection in the majority
of culture-negative mice in the primed/challenged group. Thus, despite repeated exposure of the primed/challenged mice to
Helicobacter antigens, the animals did not exhibit any
significant humoral response. Previous work with different infection
models also showed a downregulation of humoral responses following
low-dose antigen administration (3, 4, 18, 20). In the
Leishmania infection model, this was associated with a switch of the
default Th2 response of the host towards a Th1-dominant phenotype
(3, 18).
|
To determine the types of Th responses induced following exposure to a
low-dose Helicobacter inoculum, cytokine assays were performed on saponized gastric extracts from the animals using a
modification of the technique of Bergquist et al. (2).
Gamma interferon (IFN-
) and interleukin-4 (IL-4) levels in gastric tissue samples were assayed by a double sandwich enzyme-linked immunosorbent assay technique (Pharmingen Inc., San Diego, Calif.). Primed/challenged mice were found to have significantly higher gastric
IFN-
/IL-4 ratios than naive animals (Mann-Whitney test, P = 0.001), yet the gastric cytokine levels in primed/challenged mice did not differ significantly from those in naive/challenged animals (P = 0.19). Therefore the shift in the immune
responses of primed/challenged mice towards those of a predominantly
cell-mediated Th1 phenotype could not per se account for the immunity
observed in the animals. This finding would be consistent with the work of several investigators implicating both Th1 and Th2 responses in
immune clearance of Helicobacter infection following oral
immunization (11, 21). Others, however, reported that
Th2-type responses alone were responsible for protection against
Helicobacter infection (19). Clearly, further
studies are warranted to better define the type of immune responses
associated with immunity to H. pylori infection,
particularly those involved in bacterial elimination following infection.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to A. Labigne, in whose unit the work was undertaken, for her support. A. Labigne and P. J. Jenks are thanked for critical reading of the manuscript.
Financial support was provided in part by Acambis, Inc. (Cambridge, Mass.) and Aventis Pasteur Vaccins (Lyon, France). F.J.R was the recipient of a "Poste vert" postdoctoral position from the Institut de la Santé et de la Recherche Médicale, sponsored by the Conseil Régional d'Ile-de-France.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 28 Rue du Dr Roux, Paris 75724, France. Phone: 33 1 40613324. Fax: 33 1 40613640. E-mail: rferrero{at}pasteur.fr.
Present address: Genesis Research and Development, Parnell,
Auckland, New Zealand.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bancroft, A. J., K. J. Else, and R. K. Grencis. 1994. Low-level infection with Trichuris muris significantly affects the polarization of the CD4 response. Eur. J. Immunol. 24:3113-3118[Medline]. |
| 2. | Bergquist, C., A. Mattsson-Rydberg, H. Lönroth, and A.-M. Svennerholm. 2000. Development of a new method for the determination of immune responses in the human stomach. J. Immunol. Methods 234:51-59[CrossRef][Medline]. |
| 3. |
Bretscher, P. A.,
G. Wei,
J. N. Menon, and H. Bielefeldt-Ohmann.
1992.
Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.
Science
257:539-542 |
| 4. | Constant, S. L., and K. Bottomly. 1997. Induction of TH1 and TH2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322[CrossRef][Medline]. |
| 5. | Crabtree, J. E. 1993. Mucosal immune responses to Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 5(Suppl. 2):S30-S32. |
| 6. | Dubois, A., D. E. Berg, E. T. Incecik, N. Fiala, L. M. Heman-Ackah, J. Del Valle, M. Yang, H.-P. Wirth, G. I. Pérez-Pérez, and M. J. Blaser. 1999. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology 116:90-96[CrossRef][Medline]. |
| 7. | Dubois, A., D. E. Berg, E. T. Incecik, N. Fiala, L. M. Heman-Ackah, G. I. Pérez-Pérez, and M. J. Blaser. 1996. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64:2885-2891[Abstract]. |
| 8. |
Fayolle, C.,
D. O'Callaghan,
P. Martineau,
A. Charbit,
J. M. Clément,
M. Hofnung, and C. Leclerc.
1994.
Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.
Infect. Immun.
62:4310-4319 |
| 9. |
Ferrero, R. L.,
J.-M. Thiberge,
M. Huerre, and A. Labigne.
1998.
Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection.
Infect. Immun.
66:1349-1355 |
| 10. | Ferrero, R. L., J.-M. Thiberge, and A. Labigne. 1997. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology 113:185-194[CrossRef][Medline]. |
| 11. | Guy, B., C. Hessler, S. Fourage, J. Haensler, E. Vialon-Lafay, B. Rokbi, and M.-J. Quentin-Millet. 1998. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16:850-856[CrossRef][Medline]. |
| 12. | Hernandez-Pando, R., L. Pavön, K. Arriaga, H. Orozco, V. Madrid-Marina, and G. Rook. 1997. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect. Immun. 65:3317-3327[Abstract]. |
| 13. |
Keenan, J.,
J. Oliaro,
N. Domigan,
H. Potter,
G. Aitken,
R. Allardyce, and J. Roake.
2000.
Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.
Infect. Immun.
68:3337-3343 |
| 14. |
Kleanthous, H.,
G. A. Myers,
K. M. Georgakopoulos,
T. J. Tibbitts,
J. W. Ingrassia,
H. L. Gray,
R. Ding,
Z.-Z. Zhang,
W. Lei,
R. Nichols,
C. K. Lee,
T. H. Ermak, and T. P. Monath.
1998.
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
Infect. Immun.
66:2879-2886 |
| 15. | Kumagai, T., H. M. Malaty, D. Y. Graham, S. Hosogaya, K. Misawa, K. Furihata, H. Ota, C. Sei, E. Tanaka, T. Akamatsu, T. Shimizu, K. Kiyosawa, and T. Katsuyama. 1998. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J. Infect. Dis. 178:717-721[Medline]. |
| 16. | Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397[CrossRef][Medline]. |
| 17. | Menon, J. N., and P. A. Bretscher. 1996. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur. J. Immunol. 26:243-249[Medline]. |
| 18. | Menon, J. N., and P. A. Bretscher. 1998. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur. J. Immunol. 28:4020-4028[CrossRef][Medline]. |
| 19. | Mohammadi, M., J. Nedrud, R. Redline, N. Lycke, and S. Czinn. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:1848-1857[CrossRef][Medline]. |
| 20. |
Power, C. A.,
G. Wei, and P. A. Bretscher.
1998.
Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.
Infect. Immun.
66:5743-5750 |
| 21. | Radcliff, F. J., A. J. Ramsay, and A. Lee. 1997. A mixed Th1/Th2 response may be necessary for effective immunity against Helicobacter. Immun. Cell. Biol. S1:A90. |
| 22. |
Vaz, N. M., and B. B. Levine.
1970.
Immune responses of inbred mice to repeated low doses of antigen: relationship to histocompatibility (H-2) type.
Science
168:852-854 |
| 23. | Veldhuyzen van Zanten, S. J. O., P. T. Pollak, L. M. Best, G. S. Bezanson, and T. Marrie. 1994. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J. Infect. Dis. 169:434-437[Medline]. |
| 24. | Xia, H. H., and N. J. Talley. 1997. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am. J. Gastroenterol. 92:1780-1787[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»